These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 11695546)

  • 1. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
    van Steeg H; Klein H; Beems RB; van Kreijl CF
    Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.
    van Steeg H; Mullenders LH; Vijg J
    Mutat Res; 2000 May; 450(1-2):167-80. PubMed ID: 10838141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xpa and Xpa/p53+/- knockout mice: overview of available data.
    van Kreijl CF; McAnulty PA; Beems RB; Vynckier A; van Steeg H; Fransson-Steen R; Alden CL; Forster R; van der Laan JW; Vandenberghe J
    Toxicol Pathol; 2001; 29 Suppl():117-27. PubMed ID: 11695547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
    Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
    Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.
    de Vries A; van Oostrom CT; Hofhuis FM; Dortant PM; Berg RJ; de Gruijl FR; Wester PW; van Kreijl CF; Capel PJ; van Steeg H; Verbeek SJ
    Nature; 1995 Sep; 377(6545):169-73. PubMed ID: 7675086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
    Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
    Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
    Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity.
    Rebel H; Mosnier LO; Berg RJ; Westerman-de Vries A; van Steeg H; van Kranen HJ; de Gruijl FR
    Cancer Res; 2001 Feb; 61(3):977-83. PubMed ID: 11221893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
    de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
    Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
    Cleaver JE
    J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of in vivo mutations in rpsL transgene in UVB-irradiated epidermis of XPA-deficient mice.
    Murai H; Takeuchi S; Nakatsu Y; Ichikawa M; Yoshino M; Gondo Y; Katsuki M; Tanaka K
    Mutat Res; 2000 May; 450(1-2):181-92. PubMed ID: 10838142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
    Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
    Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
    Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
    Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.